Navigation Links
Quest Diagnostics Adds Timothy M. Ring to Board of Directors
Date:12/7/2011

MADISON, N.J., Dec. 7, 2011 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, today announced that its Board of Directors has elected Timothy M. Ring to serve as a director, effective immediately. Including Mr. Ring, the Board has nine members. Mr. Ring is Chairman and Chief Executive Officer of C. R. Bard, Inc., a leading multinational developer, manufacturer and marketer of innovative, life-enhancing medical technologies.

Mr. Ring joined Bard in 1992, and was named Chairman and CEO and joined Bard's Board of Directors in 2003. He is a member of the Board of Directors for AdvaMed; the National Association of Manufacturers; and the Institute for Health Technology Studies (InHealth).  He is also a trustee for the Foundation of The University of Medicine & Dentistry of New Jersey and Chairman of the Board of Trustees of the HealthCare Institute of New Jersey.

"We are excited to welcome Tim Ring as a new director," said Surya N. Mohapatra, Ph.D., Chairman and Chief Executive Officer of Quest Diagnostics. "Tim is a strong leader with broad healthcare experience and will be a valued addition to our Board."

"Quest Diagnostics plays a vital role in our healthcare system, and I am looking forward to joining its active and experienced Board," said Mr. Ring.

About Quest Diagnostics

Quest Diagnostics Incorporated (NYSE: DGX) is the world's leading provider of diagnostic testing, information and services that patients and doctors need to make better healthcare decisions. The company offers the broadest access to diagnostic testing services through its network of laboratories and patient service centers, and provides interpretive consultation through its extensive medical and scientific staff. Quest Diagnostics is a pioneer in developing innovative new diagnostic tests and advanced healthcare information technology solutions that help improve patient care. Additional company information is available at: www.QuestDiagnostics.com.

CONTACT: For Quest Diagnostics: Kathleen Valentine (Investors), +1-973-520-2900, or Gary Samuels (Media), +1-973-520-2800


'/>"/>
SOURCE Quest Diagnostics Incorporated
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Quest Diagnostics Launches Simplexa™ Dengue Test in Brazil, First Commercial Molecular Test Approved for Nations Public and Private Health Testing
2. CEOs Present and Take Questions Live, Online, December 1st at RetailInvestorConferences.com
3. Questcor Pharmaceuticals to Present at the Piper Jaffray Healthcare Conference on November 30, 2011
4. Quest Diagnostics to Speak at the Lazard Capital Markets 8th Annual Healthcare Conference
5. Questcor Pharmaceuticals to Present at CLSAs 4th Annual AsiaUSA Forum on November 7, 2011
6. Quest Diagnostics Announces Launch of Simplexa™ Direct Test for Influenza and Respiratory Viruses in Europe
7. Questcor and Child Neurology Foundation Support the 3rd Annual Infantile Spasms (IS) Awareness Week
8. Questcor Reports Third Quarter Financial Results
9. Alquest Announced as MedNet Solutions First iMedNet CRO Partner
10. Quest Introduces Its Next Generation AlphaView 4MP Medical LCD
11. Quest Diagnostics to Release Third Quarter 2011 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/20/2017)... July 20, 2017  Prime Therapeutics LLC (Prime) released this ... M.D., following today,s Institute for Clinical and Economic Review,s (ICER) ... the effectiveness and value of abuse-deterrent formulations (ADF) of opioids. ... roundtable at the meeting. ... cost benefit to the use of abuse-deterrent formulations (ADF) in ...
(Date:7/14/2017)... 2017 It should come as no surprise to ... in the midst of a crippling opioid epidemic. According to ... number of overdose deaths from opiate-based medications has quadrupled, Says, ... million dead from 2001 to 2015". During this time, the ... similarly quadrupled, drawing a compelling link between prescription and eventual ...
(Date:7/12/2017)... INDIANAPOLIS , July 12, 2017  Eli Lilly and ... settlement agreement with generic companies to resolve pending patent litigation ... Virginia regarding the Cialis ® ... expire on April 26, 2020. As part of the agreement, ... on September 27, 2018. "The unit dose patent ...
Breaking Medicine Technology:
(Date:7/24/2017)... Island (PRWEB) , ... July 24, 2017 , ... ... a new office at 2307 Bellmore Avenue, Bellmore, New York, (516) 784-5858. The ... Jordan Fabrikant, M.D. and physician assistants Lori Friedman and Fruma Leah Wiederman. ...
(Date:7/24/2017)... ... 2017 , ... “A Short Walk to the Mailbox”: a remarkable memoir of ... published author, Ed Clark. Ed Clark is a church music director and choral ... minister of music and worship leader for over fifty years. He has a ...
(Date:7/23/2017)... ... July 24, 2017 , ... Three experts ... Medicine (AAPM) 59th Annual Meeting & Exhibition, to be held in Denver, CO ... hospital administrators and journalists can visit the AAPM Facebook page to watch three ...
(Date:7/23/2017)... ... 2017 , ... Scientists from the University of Exeter reported this ... activity equivalent to a medium-paced run for pre-menopausal women, or a slow jog for ... total spine care, I understand the importance exercise can play on improving bone health. ...
(Date:7/23/2017)... ... July 23, 2017 , ... Technology is making ... patient-provider relationships. New tools are helping patients become more actively involved in their ... Care’s Most Wired® survey, released today by the American Hospital Association’s (AHA) Health ...
Breaking Medicine News(10 mins):